Inactive Instrument

News Alliqua Biomedical Inc Nasdaq

Equities

US0196213096

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

ADYNXX, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	19-12-17	AQ
Adynxx, Inc. announced that it has received $0.45 million in funding	19-12-16	CI
Adynxx, Inc. announced a financing transaction	19-11-29	CI
Adynxx Reports Third Quarter 2019 Financial Results	19-11-14	GL
Adynxx, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2019	19-11-14	CI
Adynxx : Amended Registration statement for face-amount certificate companies	19-10-11	PU
Adynxx Receives NIH HEAL Initiative Funding Award for Development of Second Non-Opioid Pain Therapeutic	19-10-02	CI
Adynxx, Inc. Announces Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2019	19-08-14	CI
Adynxx, Inc. Announces Board Changes	19-07-22	CI
Adynxx, Inc.(OTCPK:ADYX) dropped from S&P TMI Index	19-06-14	CI
Adynxx, Inc.(OTCPK:ADYX) dropped from S&P TMI Index	19-06-14	CI
Adynxx, Inc.(OTCPK:ADYX) dropped from NASDAQ Composite Index	19-06-12	CI
Adynxx, Inc. Announces Board Committee Appointments	19-05-31	CI
Adynxx, Inc. Announces Management Changes	19-05-09	CI
Adynxx, Inc.(OTCPK:ADYX) added to NASDAQ Composite Index	19-05-06	CI
Adynxx, Inc.(OTCPK:ADYX) added to S&P TMI Index	19-05-06	CI
Adynxx, Inc. completed the acquisition of Alliqua BioMedical, Inc. in a reverse merger transaction.	19-05-02	CI
Adynxx Provides Clinical Updates	19-04-22	CI
Adynxx, Inc. Announces Receipt of Notice of Award for $5.7 Million in Federal Grant Funding	18-12-13	CI
Adynxx and twoXAR Form Collaboration to Discover and Develop Treatments for Endometriosis	18-11-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Alliqua Biomedical Inc Nasdaq

Equities

US0196213096

Summary

Filters